BDRX

Biodexa Pharmaceuticals
BDRX

5 hedge funds and large institutions have $28.1K invested in Biodexa Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.6K
2
+$1.88K
3
+$924
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$220

Top Sellers

1
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$24.9K
GI
2
GAMMA Investing
California
$1.88K
Morgan Stanley
3
Morgan Stanley
New York
$924
RhumbLine Advisers
4
RhumbLine Advisers
Massachusetts
$414
CIM
5
Contravisory Investment Management
Massachusetts
$53
SS
6
SBI Securities
Japan
$1